Chronic Inflammation: The Silent Driver of Aging
Low-grade chronic inflammation is now recognised as its own hallmark of aging. Where it comes from, how to measure it, and which levers actually lower it.
The Short Answer
Chronic low-grade inflammation, often called inflammaging, is a sustained elevation of inflammatory signalling without acute infection, and it was added as its own hallmark of aging in the 2023 revision of that framework. Its sources include senescent cell secretion, mitochondrial DNA release, gut barrier permeability, visceral adipose tissue, accumulated antigenic exposure and periodontal and other low-grade infection. It is measurable through markers including high-sensitivity C-reactive protein, interleukin-6 and neutrophil-to-lymphocyte ratio, and it is among the more modifiable hallmarks: visceral fat reduction, exercise, sleep, dental health, dietary pattern and smoking cessation all lower it measurably.
Acute Versus Chronic Inflammation
Acute inflammation is a coordinated, self-limiting response: recognition of a threat, recruitment of immune cells, elimination, and then an active resolution phase driven by specialised pro-resolving mediators derived from omega-3 fatty acids. It is essential and it ends.
Chronic low-grade inflammation is different in kind rather than degree. It involves persistent low-level signalling that never resolves, with modest elevations in circulating cytokines, a shift in immune cell populations, and continuous low-grade tissue effects. It does not produce the classic signs of acute inflammation, which is why it is described as silent.
The failure is partly one of resolution rather than only of activation. If the resolution phase is inadequate, an inflammatory response does not terminate properly, and the pro-resolving mediator pathways depend on substrate availability, which is one of several mechanistic threads connecting omega-3 status to inflammatory outcomes.
Where It Comes From
- Senescent cells. Their secretory phenotype includes interleukin-6, interleukin-1 beta and matrix-degrading enzymes. Senescent burden rises with age, making this a self-reinforcing source.
- Visceral adipose tissue. Metabolically active and populated by macrophages, visceral fat is a major source of inflammatory signalling. This is why waist circumference tracks inflammatory markers better than body weight does.
- Mitochondrial damage. Mitochondrial DNA released into the cytoplasm activates pattern recognition pathways evolved to detect bacterial DNA, connecting the mitochondrial hallmark directly to the inflammatory one.
- Gut barrier permeability. Bacterial components crossing a compromised barrier trigger systemic immune activation, a mechanism supported by circulating markers of bacterial translocation rising with age.
- Periodontal and other low-grade infection. Periodontal disease is a genuinely underrated contributor, with consistent associations to systemic inflammatory markers and cardiovascular outcomes.
- Immunosenescence and antigenic load. Lifelong exposure, including persistent viral infections, shifts immune cell populations toward a more inflammatory profile.
- Sleep loss and circadian disruption. Both raise inflammatory markers in controlled human studies within days.
- Chronic psychosocial stress. Associated with elevated inflammatory markers through neuroendocrine and behavioural routes.
Note how many of these sit in other Pillars. Inflammation is less a standalone system than the common downstream consequence of dysfunction elsewhere, which is exactly why it is such a useful measurement target.
Measuring It Properly
High-sensitivity C-reactive protein. The most accessible and best-validated marker. Values under 1 mg/L are commonly described as favourable, 1 to 3 mg/L intermediate, above 3 mg/L elevated. It is an acute phase reactant, so a recent infection, injury or hard training session can raise it substantially. A single elevated value should be repeated at least two weeks later before it is interpreted, and this is the most common error in reading it.
Interleukin-6. Upstream of C-reactive protein and a strong predictor of outcomes in cohort data. Less available and more expensive, and it also rises acutely with exercise.
Neutrophil-to-lymphocyte ratio. Calculable from a standard full blood count at no additional cost, and associated with outcomes in multiple cohorts. Under-used given that most people already have the inputs.
Fibrinogen and ferritin. Both acute phase reactants that carry inflammatory information alongside their primary uses. High ferritin with normal iron indices frequently reflects inflammation rather than iron stores.
Homocysteine and uric acid. Related markers with their own significance, both associated with inflammatory and metabolic status.
What not to do. Erythrocyte sedimentation rate is too crude for optimisation purposes. Panels selling dozens of cytokines to consumers generally cannot be interpreted, because reference ranges and biological variability are poorly established for most of them.
What Lowers It, in Order of Effect
- Visceral fat reduction. The largest single lever for most people with elevated markers. Reductions in C-reactive protein with meaningful weight loss are substantial and consistent.
- Smoking cessation. Removes a continuous inflammatory stimulus.
- Exercise. Regular training lowers resting inflammatory markers despite each session raising them acutely. The adaptation, not the session, is the point, and this is why measuring the day after hard training is uninformative.
- Sleep. Restoring adequate duration and regularity lowers markers measurably.
- Dental care. Addressing periodontal inflammation lowers systemic markers, and it is cheap, specific and routinely ignored in optimisation discussions.
- Dietary pattern. Patterns high in fibre, legumes, vegetables, fish and unsaturated fats and low in ultra-processed foods associate with lower markers. Pattern-level evidence is far stronger than any single food or nutrient.
- Alcohol reduction. Dose-related contribution above moderate intake, partly through gut barrier and liver effects.
- Omega-3 intake. At doses above 2 grams per day of combined EPA and DHA, meta-analyses report reductions in C-reactive protein and interleukin-6, with the most reliable effects where baseline inflammation is elevated.
- Specific compounds. Curcumin with an absorption enhancer, and to a lesser extent other polyphenols, have modest human evidence. These sit at the end of the list rather than the beginning.
The ordering is the useful part. A person with elevated markers, high visceral adiposity and six hours of sleep will not resolve it with curcumin, and a person who has addressed the top items may find little left for a supplement to do.
The Hormesis Complication
Inflammation is not simply bad, and handling it as a quantity to minimise leads to errors.
Acute inflammatory signalling is required for training adaptation, wound healing, immune defence and tissue remodelling. Suppressing it indiscriminately has costs: non-steroidal anti-inflammatory use around training blunts some adaptation, and high-dose antioxidants around exercise blunt mitochondrial and insulin sensitivity improvements.
The objective is therefore resolution rather than suppression: a system that mounts a full response when needed and terminates it properly afterwards. That reframes the target from lowering a number to improving the dynamics, which in practice means addressing the chronic sources listed above rather than blocking the signalling.
Reassessment and Temporal Considerations
Inflammatory markers respond faster than most measures in longevity practice, which makes this Pillar unusually satisfying to track and unusually easy to misread.
A reasonable structure: measure high-sensitivity C-reactive protein and calculate neutrophil-to-lymphocyte ratio at baseline, under standardised conditions meaning no recent illness, injury or hard training in the preceding forty-eight hours. Address the top-ranked levers for twelve weeks. Re-measure under the same conditions. Twelve weeks is enough for visceral fat, sleep and training adaptations to register.
Two temporal factors matter beyond that. Seasonal variation is real, with markers tending to run higher in winter in many populations, so year-on-year comparison should ideally be season-matched. And acute events, an infection, a dental procedure, a marathon, will dominate a measurement taken near them, which means the calendar around a blood draw is part of the result.
The AEONNN Perspective
Inflammation and Immune Defense is Pillar 3, and it occupies a distinctive position in the Pillar Matrix because it is largely a downstream readout of the others. Visceral adiposity sits in Metabolic, sleep loss in Sleep, mitochondrial damage in Cellular Energy, barrier permeability in Gut-Brain. When a member's inflammatory markers are elevated, the useful question is which upstream Pillar is generating it, and that is a cross-Pillar inference rather than a compound lookup.
This is also the Pillar where measurement discipline matters most, and where AEONNN's handling of connected laboratory data has to be careful. A high-sensitivity C-reactive protein value taken two days after a hard training session or during a mild infection is not a baseline, and reading it as one would generate a false trajectory. Synched Mode weights the value against context rather than accepting it at face value.
The hormesis point shapes the recommendations directly. AEONNN does not regard inflammatory markers as a number to be minimised at all costs, because the evidence shows that suppressing acute signalling around training costs adaptation. The objective is resolution capacity, and the levers that improve it are ordinary and ordered, which is what Insight Protocol presents rather than a list of anti-inflammatory compounds.
Pillar Matrix mapping
Inflammation and Immune Defense, Longevity and Biological Age, Metabolic and Cardiovascular Health
Database Matrix layers
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Population Layer (UK Biobank, NHANES)
- Mechanistic Layer (KEGG, Reactome, UniProt)
- Real-Time User Layer (wearable and adherence signals)
Frequently Asked
What is inflammaging?
Sustained low-grade inflammatory signalling that rises with age without acute infection. It was added as its own hallmark of aging in the 2023 revision of that framework, reflecting both its independent contribution and its interaction with other hallmarks.
What is a good hsCRP level?
Values under 1 mg/L are commonly described as favourable, 1 to 3 mg/L intermediate, and above 3 mg/L elevated. It is an acute phase reactant, so a single elevated value should be repeated at least two weeks later before it is interpreted.
What lowers chronic inflammation most effectively?
Visceral fat reduction is the largest lever for most people, followed by smoking cessation, regular exercise, adequate sleep, addressing periodontal inflammation, dietary pattern change and alcohol reduction. Supplements come after these, not before.
Does exercise increase or decrease inflammation?
Both, on different timescales. Each session raises markers acutely while regular training lowers resting markers. This is why measuring the day after hard training gives a misleading result.
Is it possible to have too little inflammation?
Yes. Acute inflammatory signalling is required for training adaptation, wound healing and immune defence. Suppressing it indiscriminately with anti-inflammatory drugs or high-dose antioxidants around training blunts adaptation.
Which inflammatory test gives most value for money?
Neutrophil-to-lymphocyte ratio, because it is calculable from a standard full blood count at no additional cost and is associated with outcomes in multiple cohorts. High-sensitivity C-reactive protein is the best-validated single marker.
Can dental health really affect systemic inflammation?
Yes. Periodontal disease shows consistent associations with systemic inflammatory markers and cardiovascular outcomes, and addressing it lowers those markers. It is one of the cheapest and most specific interventions available and among the most neglected.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.